EA201791108A1 - Антибактериальные бензотиазольные производные - Google Patents

Антибактериальные бензотиазольные производные

Info

Publication number
EA201791108A1
EA201791108A1 EA201791108A EA201791108A EA201791108A1 EA 201791108 A1 EA201791108 A1 EA 201791108A1 EA 201791108 A EA201791108 A EA 201791108A EA 201791108 A EA201791108 A EA 201791108A EA 201791108 A1 EA201791108 A1 EA 201791108A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
antibacterial
benzoiazolic
derivatives
cycloprop
Prior art date
Application number
EA201791108A
Other languages
English (en)
Other versions
EA031534B1 (ru
Inventor
Кристин Шмитт
Жан-Люк Спеклен
Жан-Филипп Сюриве
Галль Шапу
Азели Мирре
Original Assignee
Идорсиа Фармасьютиклз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Идорсиа Фармасьютиклз Лтд. filed Critical Идорсиа Фармасьютиклз Лтд.
Publication of EA201791108A1 publication Critical patent/EA201791108A1/ru
Publication of EA031534B1 publication Critical patent/EA031534B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Изобретение относится к антибактериальным соединениям формулы Iгде Rозначает группу M, при этом M означает одну из групп Mи M, представленных нижегде A означает связь или C≡C; Rозначает H или галоген; Rозначает H или галоген; Rозначает H, алкокси, гидроксиалкокси, гидроксиалкил, дигидроксиалкил, 2-гидроксиацетамидо, замещенный циклопроп-1-ил или замещенный оксетан-3-ил; и Rозначает гидроксиалкил, дигидроксиалкил, аминоалкил, диалкиламиноалкил, замещенный циклопроп-1-ил, замещенный циклобутан-1-ил, замещенный оксетан-3-ил, 3-гидрокситиетан-3-ил, замещенный азетидин-3-ил, транс-{цис-3,4-дигидрокси)-циклопент-1-ил, 3-гидроксиметилбицикло[1,1,1]пентан-1-ил, 4-гидрокситетрагидро-2H-пиран-4-ил, (3R,6S)-3-аминотетрагидро-2H-пиран-6-ил, пиперидин-4-ил или 1-(2-гидроксиацетил)пиперидин-4-ил; и их солям.
EA201791108A 2014-11-19 2015-11-18 Антибактериальные бензотиазольные производные EA031534B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2014075009 2014-11-19
PCT/IB2015/058919 WO2016079688A1 (en) 2014-11-19 2015-11-18 Antibacterial benzothiazole derivatives

Publications (2)

Publication Number Publication Date
EA201791108A1 true EA201791108A1 (ru) 2017-11-30
EA031534B1 EA031534B1 (ru) 2019-01-31

Family

ID=54705241

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791108A EA031534B1 (ru) 2014-11-19 2015-11-18 Антибактериальные бензотиазольные производные

Country Status (19)

Country Link
US (1) US20170355687A1 (ru)
EP (1) EP3221300B1 (ru)
JP (1) JP2018500292A (ru)
KR (1) KR20170086079A (ru)
CN (1) CN107001300A (ru)
AR (1) AR102687A1 (ru)
AU (1) AU2015349005A1 (ru)
BR (1) BR112017010474A2 (ru)
CA (1) CA2963875A1 (ru)
CL (1) CL2017001276A1 (ru)
EA (1) EA031534B1 (ru)
HK (1) HK1243411A1 (ru)
IL (1) IL252269A0 (ru)
MX (1) MX2017006413A (ru)
PH (1) PH12017500907A1 (ru)
SG (1) SG11201703992YA (ru)
TW (1) TW201625569A (ru)
UA (1) UA118722C2 (ru)
WO (1) WO2016079688A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
AU2017267194A1 (en) * 2016-05-17 2019-01-17 Idorsia Pharmaceuticals Ltd 6-(BUTA-1,3-DIYN-1-YL)benzo[D]thiazole derivatives
CA3084809A1 (en) 2017-12-07 2019-06-13 The Regents Of The University Of Michigan Nsd family inhibitors and methods of treatment therewith

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50121218A (ru) * 1974-03-01 1975-09-23
JPH09118660A (ja) * 1995-04-10 1997-05-06 Takeda Chem Ind Ltd 芳香族ヒドロキサム酸誘導体、製造法および剤
GB9609794D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
US20040224952A1 (en) 2003-05-07 2004-11-11 Cowart Marlon D. Fused bicyclic-substituted amines as histamine-3 receptor ligands
JP2008523098A (ja) 2004-12-10 2008-07-03 エモリー・ユニバーシテイ ウィルス感染および異常細胞増殖の治療用の２′および３′−置換シクロブチルヌクレオシド類縁体
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
WO2010135536A2 (en) 2009-05-20 2010-11-25 Ardea Biosciences, Inc. Methods of modulating uric acid levels
CA2774250C (en) 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
CA2782453C (en) 2009-12-16 2015-11-24 Matthew Frank Brown N-linked hydroxamic acid derivatives useful as antibacterial agents
AU2011367819A1 (en) 2010-11-10 2013-05-02 Achaogen, Inc. Hydroxamic acid derivatives and their use in the treatment of bacterial infections
JP2014501274A (ja) 2011-01-03 2014-01-20 ハンミ ファーム． シーオー．， エルティーディー． Ｇタンパク質共役受容体調節のための新規な二環式化合物
BR112013022536B1 (pt) 2011-03-07 2020-05-26 Pfizer, Inc. Derivados flúor-piridinona, suas composições farmacêuticas e usos como agentes antibacterianos
AU2012238374B2 (en) 2011-04-08 2015-04-02 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
KR20130140164A (ko) 2011-04-08 2013-12-23 화이자 인코포레이티드 항박테리아제로서 유용한 이미다졸, 피라졸 및 트라이아졸 유도체
WO2013170030A1 (en) 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
EA030730B1 (ru) 2013-12-19 2018-09-28 Идорсиа Фармасьютиклз Лтд Антибактериальные производные 1h-индазола и 1h-индола

Also Published As

Publication number Publication date
KR20170086079A (ko) 2017-07-25
EP3221300A1 (en) 2017-09-27
CN107001300A (zh) 2017-08-01
CL2017001276A1 (es) 2018-02-16
EA031534B1 (ru) 2019-01-31
US20170355687A1 (en) 2017-12-14
SG11201703992YA (en) 2017-06-29
BR112017010474A2 (pt) 2017-12-26
JP2018500292A (ja) 2018-01-11
IL252269A0 (en) 2017-07-31
MX2017006413A (es) 2017-09-12
AR102687A1 (es) 2017-03-15
EP3221300B1 (en) 2019-03-20
TW201625569A (zh) 2016-07-16
HK1243411A1 (zh) 2018-07-13
CA2963875A1 (en) 2016-05-26
UA118722C2 (uk) 2019-02-25
PH12017500907A1 (en) 2017-11-27
AU2015349005A1 (en) 2017-07-06
WO2016079688A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
EA201791108A1 (ru) Антибактериальные бензотиазольные производные
EA201600475A1 (ru) Антибактериальные производные 1h-индазола и 1h-индола
EA201692305A1 (ru) Антибактериальные хиназолин-4(3н)-оновые производные
AU2017283790A1 (en) Substituted pyridines as inhibitors of dnmt1
PH12015502443A1 (en) 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
EA201691302A1 (ru) Новые гетероциклические соединения
EA201591457A1 (ru) Терапевтические соединения
EA201690268A1 (ru) Замещенные производные хиназолин-4-она
BR112016007757A8 (pt) Derivados antibacterianos de 2h-indazol
BR112017026682A2 (pt) novos compostos bicíclicos como inibidores de dupla ação de atx/ca
MX2017014035A (es) Formas solidas novedosas.
MX2015012363A (es) Compuestos novedosos de pidimidina y piridina y su uso.
EA201591360A1 (ru) Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
EA201691141A1 (ru) Соединения против ccr6
PH12018500323A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds
MX2018013471A (es) Nuevos compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor.
EA201691775A1 (ru) Производные 1,2-дигидро-3н-пирроло[1,2-с]имидазол-3-она и их применение в качестве антибактериальных средств
EA201790496A1 (ru) Соединения 1-алкил-6-оксо-1,6-дигидропиридин-3-ила и применение в качестве модуляторов sgrm
MX2018002027A (es) Procedimiento para la preparacion de (4s)-4-(4-ciano-2-metoxifenil o)-5-etoxi-2,8-dimetilo-1,4-dihidro-1,6-naftiridina-3-carboxamida y su purificacion para su uso como principio activo farmaceutico.
EA201890476A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНЫ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
MX2020006185A (es) Proceso para la preparacion de derivados de quinolina.
BR112015020834A2 (pt) novos derivados hidroquinolina-2-ona como inibidores de aldosterona sintetase (cyp1 1 b2 ou cyp1 1 b1)
EA201500605A1 (ru) Новые производные замещенного 1,4-дитиина и их применение в качестве фунгицидов
EA201600323A1 (ru) Производные пиперазина и их применение в качестве лекарственного средства

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU